Trials / Completed
CompletedNCT03408236
Evaluate the Safety and Efficacy of Botulax® as Compared to Botox® in Subject With Moderate to Severe Crow's Feet Lines
Randomized, Double-blind, Active-controlled, Multicenter, Phase I/III Clinical Trial to Evaluate the Safety and Efficacy of Botulax® as Compared to Botox® in Subject With Moderate to Severe Crow's Feet Lines
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 240 (actual)
- Sponsor
- Hugel · Industry
- Sex
- All
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
To determine the efficacy and safety of Botulax® in treatment of crow's feet line
Detailed description
1. Allocation: Randomized 2. Masking: Double Blind
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Botulinum toxin type A | Experimental |
| DRUG | Botulinum toxin type A | Active Comparator |
Timeline
- Start date
- 2018-01-17
- Primary completion
- 2018-12-13
- Completion
- 2019-06-07
- First posted
- 2018-01-23
- Last updated
- 2022-04-15
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03408236. Inclusion in this directory is not an endorsement.